MASTER SERVICES AGREEMENTMaster Services Agreement • November 3rd, 2011 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • New York
THIS MASTER SERVICES AGREEMENT (“MSA”) is effective as of the 29 day of March, 2010 (the “Effective Date”), by and between Celldex Therapeutics Inc. (“Celldex”) with headquarters at 119 Fourth Avenue, Needham, MA 02494, USA and Prologue Research International, Inc. (“Prologue”), with offices at 580 North Fourth Street, Suite 270, Columbus, Ohio 43215, USA.
AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • November 3rd, 2011 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances
This Amendment (“Amendment”) is entered into effective as of the last date signed below (the “Effective Date”), by and between Celldex Therapeutics, Inc., with offices located at 119 Fourth Avenue, Needham, MA 02494 (“Celldex”), and Novella Clinical Inc., a Delaware corporation with principal offices located at 4309 Emperor Blvd., Suite 400, Durham, North Carolina 27703, formerly Prologue Research Internaltional, Inc. (“Novella”).
